We look forward to releasing next month the first results of treatment with NNZ-2591 in children with PMS
So do we.
- Forums
- ASX - By Stock
- Ann: Neuren completes Phelan-McDermid syndrome Phase 2 trial
We look forward to releasing next month the first results of...
-
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.62 |
Change
-0.240(1.15%) |
Mkt cap ! $2.617B |
Open | High | Low | Value | Volume |
$20.45 | $20.62 | $20.26 | $4.698M | 229.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 221 | $20.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.62 | 1553 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 221 | 20.600 |
1 | 10 | 20.560 |
3 | 1119 | 20.550 |
1 | 665 | 20.510 |
2 | 735 | 20.500 |
Price($) | Vol. | No. |
---|---|---|
20.620 | 1553 | 1 |
20.640 | 201 | 1 |
20.660 | 322 | 1 |
20.670 | 1454 | 2 |
20.680 | 1084 | 2 |
Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |